Pubblicazioni
2026
Gobbo F., Jacob A., Pinto B., Mainardi M., Cancedda L., Cattaneo A.
Distinct spatial distribution of potentiated dendritic spines in encoding- and recall-activated hippocampal neurons
Frontiers in Molecular Neuroscience, vol. 18
2026
Costanzo F., Mongiovi V.M., Alfieri P., Pontrelli G., Abbate S., De Palma L., Chinali M., Massella L., Scorpecci A., Rocchi F., Fuca E., Averna R., Rava L., Rossetti S., Franco L., Contestabile A., Cancedda L., Vicari S.
Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial
BMJ Open, vol. 16, (no. 2)
2026
Rovere M., Beatini S., Giantomasi L., Tuntevski K., Contestabile A., De Pietri Tonelli D., Cancedda L.
Small Non-Coding RNA Dysregulation in the Microglia from a Mouse Model of Down Syndrome
FENS Forum 2026
Poster
Conference
2026
Morelli G., Visintin G., Gelli E., Serani A., Bartolucci M., Uccella S., D'Apruzzo M., Preiti D., Chellali M.M., Cucinelli A., Rastogi M., Falappa M., Scalabrini A., Turecki G., Petretto A., Tucci V., Cancedda L.
Traumatic life experiences during critical periods lead to diverse developmental trajectories
Cell Reports Medicine, vol. 7, (no. 6)
2025
Rovere M., De Pietri TOnelli D., Contestabile A., Cancedda L.
A New Potential Molecular Mechanism Linking Trisomy to Cellular Outcomes in Down Syndrome
RNA Flagship Retreat IIT
Poster
Conference
2025
Stuefer A., Colombo G., Gini S., Sastre-Yagüe D., Coletta L., Rocchi F., Aldrighetti M., D'Epifanio B., Como G., Balasco L., Barsotti N., Montani C., Alvino FG., Alberto G., Migliarini S., Bertozzi SM., Pasqualetti M., Bozzi Y., Cancedda L., Lombardo MV., Gozzi A.
Developmental excitation-inhibition imbalance permanently reprograms autism-relevant social brain circuits
BiorXiv
2025
Bolla M., Colombo G., Falappa M., Pace M., Baravalle R., Martinez N., Montani F., Tucci V., Cancedda L.
NKCC1 inhibition improves sleep quality and EEG information content in a Down syndrome mouse model
iScience, vol. 28, (no. 4)
2025
Uccella S., Potenzieri A., Marazzotta V., Cancedda L., Tucci V., Ramenghi L., Nobili L.
Preterm birth: a paradigm of sleep disruption.
OSF Preprints
2024
Portioli C., Spanò R., Murgia D., Mamberti S., Estevão B.M., Cancedda L., Decuzzi P.
Anti-inflammatory Microparticles to tackle Neurodevelopmental Disorders
Controlled Release Society
Conference Paper
Conference
2024
Ruiz Munevar M.J., Rizzi V., Portioli C., Vidossich P., Cao E., Parrinello M., Cancedda L., De Vivo M.
Cation Chloride Cotransporter NKCC1 Operates through a Rocking-Bundle Mechanism
Journal of the American Chemical Society, vol. 146, (no. 1), pp. 552-566
2024
Potenzieri A., Uccella S., Preiti D., Pisoni M., Rosati S., Lavarello C., Bartolucci M., Debellis D., Catalano F., Petretto A., Nobili L., Fellin T., Tucci V., Ramenghi L.A., Savardi A., Cancedda L.
Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target
Science advances, vol. 10, (no. 9)
2024
Colombi I., Rastogi M., Parrini M., Alberti M., Potenzieri A., Chellali M.M., Rosati S., Chiappalone M., Nanni M., Contestabile A., Cancedda L.
Heterogeneous subpopulations of GABAAR-responding neurons coexist across neuronal network scales and developmental stages in health and disease
iScience, vol. 27, (no. 4)
2024
Rastogi M., Bartolucci M., Nanni M., Aloisio M., Vozzi D., Petretto A., Contestabile A., Cancedda L.
Integrative multi-omic analysis reveals conserved cell-projection deficits in human Down syndrome brains
Neuron
2024
Marinaro G., Bruno L., Pirillo N., Coluccio M.L., Nanni M., Malara N., Battista E., Bruno G., De Angelis F., Cancedda L., Di Mascolo D., Gentile F.
The role of elasticity on adhesion and clustering of neurons on soft surfaces
Communications Biology, vol. 7, (no. 1)
2023
Smith J.B., Cancedda L., Jozwiak S., Mercer A.C.
Editorial: Viral vector-based gene therapy in neurological disease: The future is now
Frontiers in Neurology, vol. 14
2023
Savardi A., Patricelli Malizia A., De Vivo M., Cancedda L., Borgogno M.
Preclinical Development of the Na-K-2Cl Co-transporter-1 (NKCC1) Inhibitor ARN23746 for the Treatment of Neurodevelopmental Disorders
ACS Pharmacology and Translational Science, vol. 6, (no. 1), pp. 1-11
2023
Savardi A., Colombi I., Alberti M., Parrini M., Ziogas I., Borgogno M., De Vivo M., Contestabile A., Cancedda L.
Role of Intracellular Chloride Accumulation in Down Syndrome Physiopathology and Therapeutic Strategies
XXI Telethon Scientific Convention
Poster
Conference
2023
Savardi A., Borgogno M., De Vivo M., Cancedda L.
Selective NKCC1 Inhibitors for the Treatment of Drug-Resistant Epilepsy
Discussione in Epilessia Sperimentale 2
Poster
Conference